Staff Reporters
Jun 16, 2010

Adwatch: Panadol's storytelling proves contagious in Hong Kong

Kenneth Cheung praises a humorous approach to flu relief, as the SAR public rates the medicine brand highly in the recall table.

Adwatch: Panadol's storytelling proves contagious in Hong Kong

Kenneth Cheung is the creative director and founder of Lemon101 Hong Kong. Here is what he had to say about Panadol's latest TV commercial for its Panadol Extra Cold & Flu Pills brand.




All of us have to take medicine and stay in bed when we get sick from cold and flu. For Hong Kong people, especially working people, time is money in this fast-paced and cosmopolitan city. We used to complain about the low efficiency of cold and flu medication - just as the actors do in the Panadol TV commercial.

The ad impressed me - its sense of humour and the strong visual impact of the character’s hair being messed up by her neighbour sneezing all over her in the queue. The repeated storyline exhibits the fast effective relief of cold and flu symptoms with the help of this non-drowsy formulation. I love the storyline. It’s simple but it works.

Click here to view the TV recall table for Hong Kong published in the 11 March 2010 issue of Media.

Source:
Campaign China

Related Articles

Just Published

12 hours ago

Cannes Lions entries rise 'reflecting strong global ...

Entries from Latin America are up by 16%.

12 hours ago

Campaign Cannes Global Podcast Episode 1: Lions and ...

Our editors from the UK, US, Canada and APAC give their tips ahead of Cannes Lions 2025.

12 hours ago

Lindsey Evans: 'See uncertainty as opportunity'

Ahead of Cannes Lions, the chief executives of the 'big six' holding companies and senior leaders give their views on a range of topics relating to creativity and business. Today, it’s the turn of Special Australia's Lindsey Evans.

2 days ago

Agency Report Card 2024: Ogilvy

Ogilvy APAC celebrated a strong creative year in 2024, clinching top regional honours at Cannes Lions. Yet operational headwinds, particularly in China, tested its resilience and reshaped its growth strategy.